Author/Authors :
Kandemir, İdris Siirt Devlet Hastanesi - Tıbbi Mikrobiyoloji Bölümü, Turkey , Özcan, Nida Dicle Üniversitesi - Tıp Fakültesi - Tıbbi Mikrobiyoloji AD, Turkey , Alanbayı, Ümit Siirt Devlet Hastanesi - Tıbbi Mikrobiyoloji Bölümü, Turkey , Bozdağ, Hasan Midyat Devlet Hastanesi - Tıbbi Mikrobiyoloji Bölümü, Turkey , Akpolat, Nezahat Dicle Üniversitesi - Tıp Fakültesi - Tıbbi Mikrobiyoloji AD, Turkey , Gül, Kadri Dicle Üniversitesi - Tıp Fakültesi - Tıbbi Mikrobiyoloji AD, Turkey
Abstract :
Objective: Stenotrophomonas maltophilia is an opportunistic pathogen of increasing importance. Since it is intrinsically resistant to many antimicrobial agents, the treatment of S. maltophilia infections is quite difficult. The aim of this study was to investigate the distribution and antimicrobial susceptibility patterns of S. maltophilia strains isolated in four years’ time. Methods: In this study; a total of 53 S. maltophilia strains, isolated from various clinical specimens between 2011- 2015 years were investigated in terms of antibiotic resistance rates. The isolates were identified and antibiotic susceptibility tests performed by conventional methods and BD Phoenix 100 automated system (Becton Dickinson Diagnostic Systems, Sparks, USA). Results: S. maltophilia infections were mostly encountered in the intensive care units. The most effective antimicrobial agents against S. maltophilia strains were found as trimethoprim-sulfamethoxazole and levofloxacin. Conclusion: Antimicrobial susceptibility tests should be performed for nosocomial infections caused by S. maltophilia due to high antimicrobial resistance rates. If this is not possible, trimethoprim-sulfamethoxazole and levofloxacin could be good choices for empiric treatment.
NaturalLanguageKeyword :
Stenotrophomonas maltophilia , trimethoprim , sulfamethoxazole , levofloxacin , resistance
